Centene is trading at $65.72 (4.4% down) as Medicaid cost concerns and geopolitical stress weigh on the healthcare sector.
- The decline extends recent weakness tied to ongoing worries about ACA costs and future guidance.
- There are no fresh company-specific headlines or earnings releases on July 15, 2026, directly linked to the move.